Jim Kling is a Medical Writer and Journalist at MDEdge. He specializes in science and medical writing, contributing to various publications including Gastroenterology & Endoscopy News, Targeted Oncology, and Medscape, while also sharing insights on healthcare topics. Jim's work has been featured in notable outlets such as RamaOnHealthcare, showcasing his expertise in the medical field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jim Kling's coverage primarily focuses on healthcare and pharmaceutical topics, with an emphasis on scientific research. He frequently cites data in his articles, indicating a preference for evidence-based information.
To effectively reach out to Jim Kling, consider providing him with access to recent and relevant scientific studies or clinical trial data related to the topics he covers. Experts who can interpret complex medical data and provide insightful analysis would likely be valued sources for his articles.
Given the specificity of his article titles, pitching new developments in neurology, myasthenia gravis treatments, breast cancer therapies or advancements in artificial intelligence within these medical fields could capture Jim Kling's interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
March 6, 2017 | Family Practice News Use CTPA judiciously FROM CHEST
November 4, 2024 | FROM CHEST 2024 A “digital twin” model successfully predicted adverse outcomes in intensive care unit (ICU) patients treated for sepsis.
November 10, 2016 | Imprinting could influence vaccination strategies
A genetic sequencing effort found more carriers of risk genes for hereditary breast and ovarian cancer or Lynch syndrome than would have been found by following existing genetic testing guidelines.
February 22, 2017 | Family Practice News AT CROI
February 22, 2017 | Family Practice News SEATTLE – In a phase II trial, an antibody that targets domain 1 of the CD4 receptor
February 22, 2017 | SEATTLE – In patients coinfected with HIV and tuberculosis, addition of prednisone to an antiretroviral
November 10, 2019 | Family Practice News REPORTING FROM CLINICAL CONGRESS 2019
September 17, 2021 | Family Practice News FROM THE JOURNAL OF ADDICTION SCIENCE
June 25, 2020 | FROM OBSTETRICS & GYNECOLOGY Rising classes of obesity are linked with progressively increased risk of
